Back to ANTX

AN2 Therapeutics, Inc. 8-K

Accession 0001193125-23-230786

Filing information

CIK
0001880438
Report date
2023-09-01
Filing date
2023-09-08
Form
8-K
Primary document
d514862d8k.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.